Navigation Links
Johannes N. van den Anker, MD, PhD, Prominent Neonatal and Pediatric Clinical Pharmacologist, Joins NDA Partners
Date:5/15/2019

NDA Partners Chairman Carl Peck, MD, announced today that Johannes N. van den Anker, MD, PhD, a prominent neonatal and pediatric clinical pharmacologist and expert in pediatric and neonatal clinical trials and therapies, has joined the firm as an Expert Consultant.

Dr. van den Anker is Vice Chair of Pediatrics for Experimental Therapeutics, the Evan and Cindy Jones Chair in Pediatric Clinical Pharmacology, and serves as Director of the Division of Clinical Pharmacology at Children’s National Medical Center (Washington, DC). He is Professor of Pediatrics, Pharmacology & Physiology, and Genomics and Precision Medicine at The George Washington University (Washington, DC). He is also the Eckenstein-Geigy Distinguished Professor of Pediatric Pharmacology and Department Chair of Pediatric Pharmacology and Pharmacometrics, University Children’s Hospital (Basel, Switzerland), and Adjunct Professor of Medicine, Pediatrics, Pharmacology and Molecular Sciences at Johns Hopkins University School of Medicine (Baltimore, MD), and Adjunct Faculty, Intensive Care and Department of Surgery, Erasmus MC-Sophia Children’s Hospital (Rotterdam, the Netherlands). In addition to his research positions, Dr. van den Anker serves as the part-time Chief Medical Officer of ReveraGen BioPharma.

Dr. van den Anker formerly served as Director, Division of Neonatology at Sophia Children’s Hospital and as Director, Division of Pediatric Clinical Pharmacology and Medical Toxicology, at Columbus Children’s Hospital (Columbus, Ohio).

“Dr. van den Anker’s extensive knowledge of pediatric and neonatal clinical pharmacology and expertise in pediatric and neonatal therapies and clinical trials makes him an outstanding resource for assisting our clients in the design and implementation of their pediatric development programs,” said Dr. Peck. “We are delighted that he has joined NDA Partners team of Expert Consultants.”

Dr. van den Anker received his medical degree and Doctorate in Pharmacology from Erasmus University Rotterdam in Rotterdam, the Netherlands. He completed his residency in Pediatrics and a fellowship in Neonatology at Sophia Children’s Hospital in the Netherlands.

About NDA Partners
NDA Partners is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Premier Experts of NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.

Contact
Earle Martin, Chief Executive Officer
Office: 540-738-2550
MartinEarle(at)ndapartners(dot)com

Read the full story at https://www.prweb.com/releases/johannes_n_van_den_anker_md_phd_prominent_neonatal_and_pediatric_clinical_pharmacologist_joins_nda_partners/prweb16304383.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. HyGreen Partners with RCA Medical in Johannesburg, South Africa
2. NeuroCog Trials Appoints Health Care Banker, Josh Spiegel, CFA To Chief Operating Officer
3. Prominent Speakers Offer Lessons for Health and Health Care Quality Innovators
4. SMi Group Reports: 16 Prominent Updates in Pre-Filled Syringes by Big Pharma and Industry Innovators
5. The Access Group Recognized for Oncology Leadership: Agencys Oncology Business Unit Receives Praise from Prominent Industry Publication
6. Mauna Kea Technologies Cellvizio Featured Prominently at 2016 World Congress for Bronchology and Interventional Pulmonology
7. Prominent Physicians Join Juniper Pharmaceuticals Scientific Advisory Board
8. Landmark Trial Entitled "PROMINENT" To Explore The Prevention Of Heart Disease In Diabetic Patients With High Triglycerides And Low HDL-C
9. OncoSec to Present at Prominent Investment Conferences in January
10. Precision for Value Adds Prominent Health Economist Dr. Christopher Blanchette to its Expanding HEOR Team
11. New Study Suggests Prominent Role for Pharmacies In Reducing Asthma-related Illness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2019)... ... ... I W Marks Jewelers will present the $2,500 I W Loves Mom donation to ... on June 7th from 5 pm to 7 pm. , Last month, I W ... to participate in a charity challenge to celebrate Mother’s Day. The Houstonians each picked ...
(Date:5/24/2019)... ... , ... Gym Source announced support for Global Wellness Day by offering free ... 8th. “The best way to improve health and wellness is to exercise,” said ... active children, and active children become active adults. It’s a virtuous circle. In ...
(Date:5/23/2019)... Fla. (PRWEB) , ... May 23, 2019 , ... Medcom ... of the company’s visual identity. After releasing a new logo and name extension last ... The new website is designed to be extremely user-friendly with key elements found across ...
Breaking Medicine Technology:
(Date:5/24/2019)... ... ... NJ Top Docs is proud to present Dr. William F. Ziegler for ... staying abreast of new developments in reproductive medicine will provide his patients with the ... treat patients; he wants to be a part of their journey, working with them ...
(Date:5/23/2019)... , ... May 23, 2019 , ... In the U.S. ... in 1,092 embryo transfer procedures, the last step in the in vitro fertilization (IVF) ... just five years earlier.[1] Dr. Mark P. Trolice, Director of Fertility CARE: The ...
(Date:5/23/2019)... ... May 23, 2019 , ... Dr. Earl Stephenson, ... network. , The Haute Beauty Network, well known for their exclusivity, and luxurious ... our newest addition to the Haute Living partnership. , Haute Beauty offers a ...
(Date:5/23/2019)... ... ... Four years after losing her daughter to injuries sustained during an stone-throwing attack in the ... Sheba Medical Center, Tel HaShomer . The baby was born on the same birth ... life. , “Just as we live with our loss 24/7, we are choosing life and ...
(Date:5/23/2019)... , ... May 23, 2019 , ... ... health services, announces the opening of its seventeenth treatment center, Bel Aire Recovery ... is Summit’s first in the Sunflower State. The facility is located in the ...
Breaking Medicine News(10 mins):